Nanoparticle formulation of ormeloxifene for pancreatic cancer

Pancreatic cancer is the fourth most prevalent cancer with about an 85% mortality rate; thus, an utmost need exists to discover new therapeutic modalities that would enhance therapy outcomes of this disease with minimal or no side effects. Ormeloxifene (ORM), a synthetic molecule, has exhibited pote...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomaterials
Autors principals: Khan, Sheema, Chauhan, Neeraj, Yallapu, Murali M., Ebeling, Mara C., Balakrishna, Swathi, Ellis, Robert T., Thompson, Paul A., Balabathula, Pavan, Behrman, Stephen W., Zafar, Nadeem, Singh, Man Mohan, Halaweish, Fathi T., Jaggi, Meena, Chauhan, Subhash C.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4405677/
https://ncbi.nlm.nih.gov/pubmed/25890768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2015.02.082
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars